Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

Back to Intelligence
Dubai prescription medicine costs in 2026: AED 4.50 generics to AED 21,108 cancer packs

Dubai prescription medicine costs in 2026: AED 4.50 generics to AED 21,108 cancer packs

A practical guide to what patients pay for prescription drugs in Dubai in 2026. Includes retail price examples, insurance limits and where to verify licensed pharmacies.

Zavis Intelligence·Healthcare Industry Desk
3 Sept 2026·3 min read

How Zavis verifies this coverage

Editorial standards, source rules, methodology, and review provenance are public.

Prescription medicine in Dubai in 2026 can cost AED 4.50 for a 24-tablet paracetamol pack, AED 14 for 50 tablets of metformin 500 mg, AED 259 for 30 tablets of branded atorvastatin 20 mg, and more than AED 20,000 for selected oncology packs.

The highest-stakes readers are CFOs, COOs and pharmacy operators. CFOs need to know what hits claims cost and cash collection. COOs need formulary, licence and e-claim controls. Pharmacy owners need to track federal price changes because a lower official retail price can compress gross margin the same day it helps patient affordability.

Who sets the price

In Dubai, the facility regulator is the Dubai Health Authority (DHA). Medicine registration and pricing sit at federal level with the Ministry of Health and Prevention (MOHAP) and the Emirates Drug Establishment (EDE). Abu Dhabi operators also work under the Department of Health Abu Dhabi (DOH), while pharmacies in Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain follow federal MOHAP and EDE controls.

MOHAP's pharmaceutical pricing rules were listed as updated on 10 July 2026. The practical point for operators is simple: the shelf price is not just a commercial decision by the pharmacy. Registered products have approved prices, and insurers then apply networks, formularies, deductibles and co-payment rules.

EDE cut prices for 168 pharmaceutical products from 30 May 2026, according to a Gulf News report on the EDE decision. The reductions covered cardiovascular disease, diabetes, hypertension, cancer, thrombosis, cholesterol disorders, gastrointestinal disease, neurological disease, eye disease and asthma. Reported cuts ranged from about 5% to nearly 60%.

What patients actually see at the pharmacy

Retail prices visible on Dubai-facing pharmacy sites give a working range, but they should be checked at the point of sale. On 3 September 2026, Life Pharmacy listed Panadrex 500 mg 24 tablets at AED 4.50, Glucophage 500 mg 50 tablets at AED 14, and Lipitor 20 mg 30 tablets at AED 259, all shown inclusive of VAT.

High-cost medicines sit in a separate category. EDE's May 2026 price decision reduced Alunbrig 180 mg from AED 26,433 to AED 21,108, Alunbrig 90 mg from AED 19,824 to AED 12,520, and Alunbrig 30 mg from AED 6,608 to AED 4,173, according to the Gulf News report. Life Pharmacy also listed Mounjaro KwikPen 5 mg at AED 1,560.60 on the same date.

  • Low-cost pain and fever medicines: about AED 4.50 to AED 30 in visible online retail examples.
  • Common chronic medicines: about AED 14 for metformin 500 mg and AED 259 for a branded statin example.
  • Injectable metabolic medicines: about AED 1,560.60 in one Dubai online listing for Mounjaro.
  • Selected oncology medicines: EDE-linked examples after the May 2026 cut ranged from AED 4,173 to AED 21,108.

Insurance is the real bill

The patient bill depends on the insurer more than the sticker price. Dubai's mandatory insurance market includes DHA-compliant plans sold by participating insurers, and Sukoon is one insurer active in that segment. Abu Dhabi's market includes Daman, which publishes a drug formulary; the page showed a 01.09.2026 downloadable file when checked.

For lower-cost Dubai cover, public plan summaries continue to cite an annual pharmacy benefit around AED 1,500 and prescription co-insurance around 30% for Essential Benefits Plan-style products. Operators should confirm the exact number on the member's policy schedule before dispensing, because pharmacy sub-limits and rejected medicines create receivables risk at the counter.

Abu Dhabi has its own verification path. DOH lists a Search for DOH Approved Drug tool, where users can search by brand name, generic name or drug code. The same DOH page also lists a pharmacy finder. For Daman and Thiqa patients, formulary status, prior approval and network pharmacy rules determine whether the medicine is paid at direct billing, reimbursed later, or paid in cash.

The operational action is to quote patients in two numbers: the approved or listed retail price, then the expected out-of-pocket amount after formulary and co-payment checks. Dubai pharmacies should keep DHA licence status current, check MOHAP and EDE price updates, and retain itemised receipts for claim disputes. Abu Dhabi pharmacies should use DOH drug and pharmacy tools. Northern Emirates pharmacies should verify MOHAP/EDE product status before promising availability.

For a licensed provider check before dispensing or referral, use the UAE Open Healthcare Directory to find licensed pharmacy providers across Dubai, Abu Dhabi and the northern emirates.

ZI

Zavis Intelligence

Healthcare Industry Desk

Contributing to UAE healthcare industry coverage

Source: Business Post Nigeria

FAQ

What is happening in UAE healthcare industry?

A practical guide to what patients pay for prescription drugs in Dubai in 2026. Includes retail price examples, insurance limits and where to verify licensed pharmacies.